Form 6-K Adaptimmune Therapeutics For: Nov 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Adaptimmune Therapeutics (ADAP) Narrows Q1 Loss
November 13, 2015 8:00 AM ESTAdaptimmune Therapeutics (NASDAQ: ADAP) reported Q1 EPS of $-0.00, versus (GBP0.01) reported last year. Revenue for the quarter came in at GBP2.6 million, versus GBP944 thousand reported last year.
Adaptimmune is reiterating its cash burn guidance. For the six months ending December... More
